Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Initial Study of FDG-PET/CT and MRI to Assess Thymic Function

NCT02909075 is registered in ClinicalTrials.gov with Memorial Sloan Kettering Cancer Center as lead sponsor.

NCT NCT02909075
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02909075 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Initial Study of FDG-PET/CT and MRI to Assess Thymic Function
Lead sponsor
Memorial Sloan Kettering Cancer Center
Phase
Observational
Overall status
Completed
Start date
August 31, 2016
Completion date
January 31, 2020
Enrollment
3 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

cd34 selected peripheral blood stem cell graft